CAPITAL4 NEWS

 

  • NIFTY4,860.5  
  • -45.6 -0.9%
  • SENSEX16,026.4  
  • -156.9 -1.0%

Glenmark Generics gets tentative approval for Montelukast Sodium 10 mg tablets

Source: Capital Market, Monday, November 28th, 03:39 PM

Glenmark Generics Inc., USA, the United States subsidiary of Glenmark Generics has received tentative approval from United States Food and Drug Administration (USFDA) for Montelukast Sodium 10 mg tablets, their generic version of Singulair tablets by Merck.

IMS Health has recorded sales of Singulair 10 mg tablets for the 12 month period ending September 2011 as $3.2 billion. Based on the tentative approval for Montelukast Sodium tablets, Glenmark Generics should be able to launch the product upon patent expiry in August 2012.

The company made this announcement during the trading hours today, 28 November 2011.

TOP BLOGS

View all blogs